Monika Kirsnytė-Šniokė

Dr. Monika Kirsnytė-Šniokė


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2025 in Nanomaterials
Verified
Journal Article
Open access
PDF file
MKMUHAMMAD USMAN Khalid
MUHAMMAD USMAN Khalid
ARAustėja Rudokaitė
Austėja Rudokaitė
Alessandro Marcio Hakme da SilvaAlessandro Marcio Hakme da Silva
Alessandro Marcio Hakme da Silva
MKMonika Kirsnytė-Šniokė
Monika Kirsnytė-Šniokė
Arunas StirkeArunas Stirke
Arunas Stirke
WMWanessa Melo
Wanessa Melo
Niobium nanoparticles (NbNPs) have gained attention as promising materials in biomedical applications due to their exceptional biocompatibility, corrosion resistance, and versatility. These nanoparticles offer potential in drug delivery, imaging, and tissue engineering, where their nanoscale properties allow precise interactions with biological systems. Among niobium-based nanomaterials, niobium pentoxide (Nb2O5) is the most extensively studied due to its chemical stability, bioactivity, and optical properties. Nb2O5 nanoparticles have shown significant potential in catalysis, biosensing, and photodynamic therapy, as their stability and reactivity make them ideal for functionalization in advanced biomedical applications. Despite these advantages, challenges remain regarding the biodegradability and long-term retention of NbNPs in biological systems. Their accumulation in tissues can lead to risks such as chronic inflammation or toxicity, emphasizing the importance of designing nanoparticles with controlled clearance and biodegradability. Surface modifications, such as coatings with biocompatible polymers, have demonstrated the ability to mitigate these risks while enhancing therapeutic efficacy. This review provides a comprehensive overview of NbNPs, with a focus on Nb2O5, highlighting their unique properties, current biomedical applications, and limitations. By addressing the remaining challenges, this work aims to guide the development of safer and more effective niobium-based nanomaterials for future medical innovations.

Verified
Journal Article
Open access
PDF file
ASAntanas Straksys
Antanas Straksys
AAAdei Abouhagger
Adei Abouhagger
MKMonika Kirsnytė-Šniokė
Monika Kirsnytė-Šniokė
TKTatjana Kavleiskaja
Tatjana Kavleiskaja
Arunas StirkeArunas Stirke
Arunas Stirke
WMWanessa Melo
Wanessa Melo
Photoactive hydrogels facilitate light-triggered photochemical processes, positioning them as innovative solutions in biomedical applications, especially in antimicrobial photodynamic therapy. This study presents a novel methylene blue-based photoactive hydrogel designed as a topical gel solution to overcome the limitations of traditional pad-based systems by offering enhanced adaptability to irregular wound surfaces, uniform photosensitizer distribution, and deeper therapeutic light penetration. This study investigated the development of hydrogels by cross-linking gelatin with glutaraldehyde (GA) and incorporating methylene blue (MB) to investigate the effects of cross-linking density, network structure, and small molecule inclusion on hydrogel properties. The results showed that while glutaraldehyde concentration influenced swelling behavior and network structure, the inclusion of MB altered these properties, particularly reducing swelling and MB retention at higher GA concentrations. Rheological and thermal analyses confirmed that higher GA concentrations made the hydrogels more rigid, with MB influencing both mechanical and thermal properties. Additionally, the hydrogels exhibited enhanced antimicrobial properties through increased reactive oxygen species production, particularly in light-activated conditions, demonstrating the potential of MB-based photoactive hydrogels for improving antimicrobial efficacy, especially against S. aureus, E. coli, and C. albicans, offering as a possible alternative to traditional antimicrobial treatments.